Nathan Livers, MD
Obstetrics & Gynecology · Little Rock, ARNPI 1356509236
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,570 of the $5,181 with a category attached, or 68.9%. 32 manufacturers reported payments, led by Bayer at 27.7% of the total. 2025 is the largest year on record at $1,502, 3.6 times the $413 reported in 2019.
Across 141 payments — averaging $36.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$1K
- Modernatx, Inc.$1K
- AbbVie$679
- Astellas Pharma US Inc$482
- Caldera Medical, Inc$195
- Coopersurgical, Inc.$121
- plus $1K from 26 others
Across 323 payments — averaging $4552.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$1.3M
- Evofem Biosciences, Inc.$81K
- AbbVie$66K
- Rejoni Inc.$57K
What the payments were for
- Travel & lodging$1,30425%
- Food & beverage$3,57069%
- Education$3076%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 21 | $1,435 |
| Modernatx, Inc. | 4 | $1,225 |
| AbbVie(2 entities) | 40 | $679 |
| Astellas Pharma US Inc | 14 | $482 |
| Caldera Medical, Inc | 2 | $195 |
| Coopersurgical, Inc. | 1 | $121 |
| Gynesonics, Inc. | 1 | $96 |
| Avion Pharmaceuticals | 6 | $87 |
| Rhythm Pharmaceuticals, Inc. | 1 | $76 |
| Organon | 7 | $72 |
| Pfizer | 4 | $66 |
| Davol Inc. | 1 | $58 |
| Exeltis, USA Inc. | 4 | $57 |
| Merck | 4 | $56 |
| Mayne Pharma Commercial LLC | 5 | $52 |
| Biogen | 2 | $45 |
| Therapeuticsmd, Inc. | 3 | $44 |
| Hologic Sales And Service, LLC | 3 | $40 |
| Mylan Pharmaceuticals Inc. | 3 | $40 |
| Johnson & Johnson | 1 | $38 |
| Shield Therapeutics Inc | 2 | $34 |
| Millicent US Inc | 1 | $26 |
| Scynexis, Inc. | 1 | $26 |
| AMAG Pharmaceuticals, Inc. | 2 | $22 |
| BD | 1 | $20 |
| Meditrina | 1 | $16 |
| Smith+Nephew | 1 | $14 |
| Evofem Biosciences, Inc. | 1 | $13 |
| Lupin Inc. | 1 | $13 |
| Minerva Surgical, Inc | 1 | $13 |
| Covidien LP | 1 | $11 |
| Myovant Sciences Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,181 in reported general payments places this provider in the 85th percentile of 272 obstetrics & gynecology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 51 | $11,605 |
| Estradiol | 65 | $1,883 |
| Estradiol (Twice Weekly)Estradiol | 25 | $1,721 |
| Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet | 27 | $1,650 |
| Topiramate | 11 | $99 |
| Fluconazole | 11 | $54 |
| Norethindrone Acetate | 11 | $52 |
| Sertraline Hcl | 13 | $49 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $66 | $11,60551 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 272 obstetrics & gynecology providers in Arkansas.
Other obstetrics & gynecology in Little Rock
- Michael CopeLittle Rock$147K
- David ShenkerLittle Rock$28K
- Julia GoodwinLittle Rock$16K
- Ananth RanganathanLittle Rock$11K
- Mary RacherLittle Rock$11K
- Nirvana ManningLittle Rock$10K
- Sharai AmayaLittle Rock$9K
- Emily WilliamsLittle Rock$9K
- Shelly GibbsLittle Rock$8K
- Stacy Ulmer-PinterLittle Rock$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.